Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.
TipRanks on MSN
Incyte’s INCA33890: A Promising Step in Cancer Treatment
Incyte (($INCY)) announced an update on their ongoing clinical study. Incyte Corporation is currently conducting a Phase 1 clinical study titled A ...
Merus (MRUS) announced interim clinical data as of a July 29, 2025 data cutoff from the ongoing phase 2 trial of the bispecific antibody ...
L left-sided mCRC (n=8, confirmed and unconfirmed) – 62% response rate in 2L left- and right-sided mCRC (n=13, confirmed and unconfirmed) UTRECHT, The Netherlands and CAMBRIDGE, Mass., Oct. 24, 2025 ...
Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the expansion of its Phase III ...
Petosemtamab plus FOLFOX: Most frequent treatment-emergent adverse events (TEAEs) regardless of causality (all Grades [G]/G3) were dermatitis acneiform (71%/0%), constipation (43%/0%), fatigue (43%/0% ...
Primary bladder mucinous adenocarcinoma (BMA) is an exceedingly rare and aggressive malignancy. We report a case of a 72-year-old male presenting with hematuria and dysuria. Imaging revealed a bladder ...
A new treatment strategy tested by UCLA researchers could offer new hope for men whose prostate cancer has returned after initial treatment. This approach could also help delay the need for hormone ...
Every week neurologist Victor Sung sees people with Huntington’s disease, a rare and devastating neurodegenerative disorder, at his clinic at the University of Alabama at Birmingham. But last ...
Bryce Vissel does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...
It sounds counterintuitive: Eat more fat and lose more weight. But it's the underpinning of a keto diet -- a controversial eating regimen designed to retrain the body to rely on something other than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results